Vaccination Response in immunoCompromised Host 2.

Comparison of antibody response upon influenza vaccination after intradermal versus intramuscular injection in immunocompromized hosts.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26830

Enrollment

580

Registered

2005-09-08

Start date

2005-10-04

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV, hemodialysis, bonemarrow transplant, reumatologic patients, lung transplant patients.

Interventions

1. Intradermal vaccination

2. Intramuscular vaccination.

Eligibility

Inclusion criteria

Inclusion criteria: Immunocompromized patients at least 18 years of age.

Exclusion criteria

Exclusion criteria: 1. Active infection; 2. Pregnancy; 3. Life expectancy of less than 6 months; 4. Thrombocetopenia; 5. Coumarin therapy; 6. Thinskin with steroids; 7. Known allergies; 8. Influenza vaccination within last 9 months.

Design outcomes

Primary

Measure	Time frame
GMT 30 days post vaccination.	—

Secondary

Measure	Time frame
Protection rates.	—

Contacts

Public ContactL.B.S. Gelinck

Leiden University Medical Center (LUMC), P.O. Box 9600

L.B.S.Gelinck@LUMC.nl+31 (0)71 5269111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)